GSK Teams with Aspen to Bring Generics to Japan

Oct 09, 2014

Reuters Africa

Aspen Pharmacare Holdings, Africa's biggest generic drugmaker, has teamed up with shareholder GlaxoSmithKline to extend presence in Japan, the world's second-biggest pharmaceutical market.

The transaction, which is expected to be completed by next year, involves Aspen selling a 25 percent stake in a newly established Japanese business to GSK, which already owns about 12 percent of Aspen.

GSK will then transfer distribution rights of certain products to the new entity, Aspen Japan. GSK would also provide Aspen Japan with a pipeline of other generic medicines.

Read the Reuters release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments